中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Potent and selective inhibition of magnolol on catalytic activities of UGT1A7 and 1A9

文献类型:期刊论文

作者Zhu, Liangliang1,2; Ge, Guangbo1; Liu, Yong1; He, Guiyuan1,2; Liang, Sicheng1; Fang, Zhongze1,2; Dong, Peipei3; Cao, Yunfeng1; Yang, Ling1
刊名xenobiotica
出版日期2012-10-01
卷号42期号:10页码:1001-1008
关键词Magnolol UDP-glucuronosyltransferases glucuronidation UGT inhibitor
产权排序1,1
通讯作者杨凌
英文摘要1. human exposure to magnolol can reach a high dose in daily life. our previous studies indicated that magnolol showed high affinities to several udp-glucuronosyltransferases (ugts) this study was designed to examine the in vitro inhibitory effects of magnolol on ugts, and further to evaluate the possibility of the in vivo inhibition that might happen.
学科主题物理化学
类目[WOS]pharmacology & pharmacy ; toxicology
研究领域[WOS]pharmacology & pharmacy ; toxicology
关键词[WOS]human udp-glucuronosyltransferases ; human liver-microsomes ; in-vitro ; glucuronidation ; kinetics ; androsterone ; specificity ; enzymes ; single ; ugt2b7
收录类别SCI
语种英语
WOS记录号WOS:000308411600006
公开日期2013-10-11
源URL[http://159.226.238.44/handle/321008/118185]  
专题大连化学物理研究所_中国科学院大连化学物理研究所
作者单位1.Chinese Acad Sci, Dalian Inst Chem Phys, Lab Pharmaceut Resource Discovery, Dalian 116023, Peoples R China
2.Chinese Acad Sci, Grad Univ, Beijing, Peoples R China
3.Dalian Med Univ, Res Inst Integrated Tradit & Western Med, Dalian, Peoples R China
推荐引用方式
GB/T 7714
Zhu, Liangliang,Ge, Guangbo,Liu, Yong,et al. Potent and selective inhibition of magnolol on catalytic activities of UGT1A7 and 1A9[J]. xenobiotica,2012,42(10):1001-1008.
APA Zhu, Liangliang.,Ge, Guangbo.,Liu, Yong.,He, Guiyuan.,Liang, Sicheng.,...&Yang, Ling.(2012).Potent and selective inhibition of magnolol on catalytic activities of UGT1A7 and 1A9.xenobiotica,42(10),1001-1008.
MLA Zhu, Liangliang,et al."Potent and selective inhibition of magnolol on catalytic activities of UGT1A7 and 1A9".xenobiotica 42.10(2012):1001-1008.

入库方式: OAI收割

来源:大连化学物理研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。